ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2026
Cervical Cancer Screening and Prevention among Latinas in the United States among a Network of Community Health Centers.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundTimely cervical cancer screenings are critical for middle-aged to older Latinas. However, little is currently known about screening in this population. Latinas tend to receive disproportionate care in community health centers (CHC).
methodsA retrospective analysis of electronic health record data from a national network of US CHCs included Latinas and non-Hispanic Whites (NHW) aged >45 with known birth country and at least one in-person primary care visit between 2014 and 2022, across 527 community-based clinics in 15 states. We used generalized estimating equations logistic regression to examine covariate-adjusted receipt of cytology, overall and by country of origin.
resultsAmong 34,135 patients, Mexican Latinas had the highest unadjusted prevalence of receiving cytology or cotesting at 56%, whereas NHWs had the lowest prevalence at 37%. We found that Latina groups, except for US-born Latinas, individually had higher odds of receiving cytology or cotesting compared with NHWs. Latina groups born in Mexico [OR (95% confidence interval, CI), 1.44 (1.09-1.90)], Honduras [OR (95% CI), 1.39 (1.06-1.82)], El Salvador [OR (95% CI), 1.38 (1.09-1.73)], and Nicaragua [OR (95% CI), 1.36 (1.01-1.83)] had higher odds than NHWs.
conclusionsCHCs have important strengths in reaching diverse patient populations, with higher rates of cervical cancer screening in middle-aged to older Latinas than NHWs. IMPACT: This study adds novel information about screening rates among a heterogeneous sample outside of their reproductive years and in a large, multistate sample of CHCs. We add to a growing body of literature about the distinctive environment of CHCs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.